Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial

Overview of attention for article published in British Journal of Dermatology, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#47 of 9,537)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Dimensions has found 15 publications that cite this research output.

Article in Annals of Pharmacotherapy (May 2024)

Article in Dermatologic Clinics (April 2024)

Article in Journal of the European Academy of Dermatology and Venereology (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.